CAJ | 학술논문

目的探讨噻托溴铵对中重度稳定期慢性阻塞性肺疾病(COPD)患者生活质量的改善情况.方法选取中重度稳定期COPD患者80例,随机分为常规治疗组与噻托溴铵治疗组各40例,比较两组患者治疗前后6MWT、CAT、肺功能、MRC评分.结果两组患者在治疗1年后生活质量相关指标均较治疗前改善(P<0.05、P<0.01),但噻托溴铵组较对照组改善更为明显(P<0.01).结论噻托溴铵不仅能够明显改善中重度COPD患者的呼吸功能,而且能够明显改善患者的健康相关生活质量.
목적탐토새탁추안대중중도은정기만성조새성폐질병(COPD)환자생활질량적개선정황.방법선취중중도은정기COPD환자80례,수궤분위상규치료조여새탁추안치료조각40례,비교량조환자치료전후6MWT、CAT、폐공능、MRC평분.결과량조환자재치료1년후생활질량상관지표균교치료전개선(P<0.05、P<0.01),단새탁추안조교대조조개선경위명현(P<0.01).결론새탁추안불부능구명현개선중중도COPD환자적호흡공능,이차능구명현개선환자적건강상관생활질량.
Objective Investigate tiotropium improved quality of life in patients with moderate to severe stable chronic obstructive pulmonary disease(COPD). Methods Select 80 cases of patients with moderate to severe stable COPD were randomly divided into conventional treatment group with tiotropium treatment group, Each group of 40 people. Each group of patients before and after treatment of 6MWT, CAT, Pulmonary function, MRC score. Results Improve relevant indicators of the quality of life of patients in both groups after 1 year of treatment than before treatment(P<0.05, P<0.01), but the tiotropium group compared with the control group improved more significantly(P<0.01). Conclusions Tiotropium significantly improved respiratory function in patients with moderate to severe COPD, but also can significantly improve patients' health-related quality of life.